ALA 6.45% 16.5¢ arovella therapeutics limited

March, page-4

  1. 4,733 Posts.
    lightbulb Created with Sketch. 242
    Hi matrix

    You will no doubt not forgotten that the WHO MPAC are meeting in Geneva 5-7th March. I am really hopeful that from this meeting will be some clear direction for the use of ArTiMist as a Pediatric pre-referral treatment. I am also hopeful there may be some further mention of a sponsored trial programme for extending the use of ArTiMist to adults. It usually takes a little while for the outcomes from these meetings to be published.

    kippax
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
0.010(6.45%)
Mkt cap ! $173.5M
Open High Low Value Volume
15.5¢ 16.5¢ 15.5¢ $137.5K 864.3K

Buyers (Bids)

No. Vol. Price($)
2 268567 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 535651 10
View Market Depth
Last trade - 16.10pm 09/10/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.